In the present study, 600 patients with gastrointestinal disorders were included. A total of 28 individuals (13 women and 15 men) had been diagnosed with CRC. However, there was no statistically significant relationship between CRC and gender. Gao et al., in a study on 313,350 new cases of CRC, found that more men were diagnosed with CRC (162,741 men versus 150,609 women). They reported that the age-adjusted incidence of CRC was higher in men than women (
8). Also, de Kok et al. reported that the age-standardized incidence rate of CRC was 40.1 per 100,000 person-years in males and 29.4 per 100,000 person-years in females (
9). Abotchie et al. showed that the incidence rate ratio for CRC between males and females was 1.38 (
10). Overall, it has been suggested that the lifetime risk of CRC is similar in males and females; however, the incidence rate is higher in men due to a longer life expectancy in women (
4). We found no statistically significant relationship between CRC and age. Inconsistent with our findings, it has been reported that the incidence rate of CRC increases rapidly with age (
4). Siegel et al. found that 60% of CRC cases occurred in individuals aged ≥ 65 years (
11). However, the proportion of cases diagnosed with CRC before the age of 50 years has increased in recent decades (
12). In our study sample, 17 out of 28 patients with CRC were young and middle-aged, which may indicate that the age at diagnosis is lower in the Persian population than in other populations. In the present study, there was no considerable relationship between CRC and the history of IBD. The relationship between IBD and CRC has been described in several studies. Gillen et al. found an 18-fold rise in the risk of developing CRC in patients with Crohn's colitis and a 19-fold rise in patients with ulcerative colitis compared to the general population (
13). However, Jess et al. reported that the overall risk of CRC among individuals with ulcerative colitis was similar to that of the general population (
14). We found no remarkable relationship between CRC and a family history of CRC. In contrast to our study, Weigl et al. found a strong association between family history and CRC risk (
15). Roos et al., in a meta-analysis, reported a relative risk of 1.92 for CRC in patients with 1 first-degree relative in case-control studies and 1.37 in cohort studies (
16). Savijärvi et al. reported that colon cancer incidence was higher among individuals with high educational levels (
17). However, the present study had no statistically significant association between CRC and educational levels. We found no significant relationship between CRC and smoking. In contrast to our study, Botteri et al., in a meta-analysis, concluded that cigarette smoking was considerably associated with CRC incidence (
18). Also, Liang et al. reported a 17% higher risk of developing CRC in smokers than those who never smoked (
19). There was no significant relationship between CRC and a history of drug use. However, Naghibzadeh-Tahami et al., in a case-control study, concluded that opioid use could increase CRC risk (
20). Furthermore, Bidary et al. reported an increased risk of colon cancer in opium consumers compared to non-consumers (
21). In the present study, 23 out of 28 patients with CRC were married. There was a significant relationship between CRC and marital status. Li et al. reported that 55.20% of CRC patients were married and had a survival advantage (
22). The differences observed between our findings and previous studies' findings may reflect the presence of latent genetic disorders and unknown environmental risk factors among our population. This may indicate the need for designing screening programs according to the epidemiological features of this population. Currently, several screening programs have been recommended for CRC. Based on the U.S. Multi-Society Task Force on Colorectal Cancer, screening should be suggested to all average-risk people aged 45 to 49. If they have not begun screening before 50, they should be suggested to initiate screening at 50. A colonoscopy every 10 years or an annual fecal immunochemical test (FIT) are the first-line options for screening (
23).